HQL
1832 Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-13,050
| Closed | -$272K | – | 785 |
|
|
2021
Q3 | $272K | Sell |
13,050
-81,950
| -86% | -$1.71M | ﹤0.01% | 632 |
|
|
2021
Q2 | $2.02M | Sell |
95,000
-208,800
| -69% | -$4.44M | ﹤0.01% | 424 |
|
|
2021
Q1 | $5.94M | Sell |
303,800
-139,296
| -31% | -$2.73M | 0.01% | 346 |
|
|
2020
Q4 | $8.8M | Buy |
443,096
+8,696
| +2% | +$173K | 0.02% | 297 |
|
|
2020
Q3 | $7.67M | Hold |
434,400
| – | – | 0.02% | 283 |
|
|
2020
Q2 | $7.73M | Buy |
434,400
+149,400
| +52% | +$2.66M | 0.02% | 257 |
|
|
2020
Q1 | $4.31M | Buy |
285,000
+159,066
| +126% | +$2.41M | 0.02% | 310 |
|
|
2019
Q4 | $2.2M | Buy |
125,934
+45,934
| +57% | +$803K | 0.01% | 378 |
|
|
2019
Q3 | $1.21M | Hold |
80,000
| – | – | ﹤0.01% | 419 |
|
|
2019
Q2 | $1.34M | Buy |
+80,000
| New | +$1.34M | ﹤0.01% | 446 |
|